AIM ImmunoTech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AIM ImmunoTech and buy or sell other stocks, ETFs, and their options commission-free!About AIMI
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen.
CEOThomas Kenwood Equels
CEOThomas Kenwood Equels
Employees23
Employees23
HeadquartersOcala, Florida
HeadquartersOcala, Florida
Founded1966
Founded1966
Employees23
Employees23
AIMI Key Statistics
Market cap196.53K
Market cap196.53K
Price-Earnings ratio-0.07
Price-Earnings ratio-0.07
Dividend yield—
Dividend yield—
Average volume62.98K
Average volume62.98K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$36.00
52 Week high$36.00
52 Week low$1.26
52 Week low$1.26
Stock Snapshot
The current AIM ImmunoTech(AIMI) stock price is $0.07, with a market capitalization of 196.53K. The stock trades at a price-to-earnings (P/E) ratio of -0.07.
During the trading day, AIM ImmunoTech(AIMI) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for AIM ImmunoTech(AIMI) stock has reached 0, versus its average volume of 62.98K.
The stock's 52-week range extends from a low of $1.26 to a high of $36.00.
The stock's 52-week range extends from a low of $1.26 to a high of $36.00.
People also own
Based on the portfolios of people who own AIMI. This list is generated using Robinhood data, and it’s not a recommendation.